Becton, Dickinson and Company (BD), a leading global medical technology company, announced the appointment of Patrick Kaltenbach as executive vice president and chief technology officer, and the promotion of Dave Hickey to executive vice president and president, Life Sciences segment, both effective January 1, 2021.
Kaltenbach, will be responsible for continuing to drive the company’s category innovation strategy and leading all research and development (R&D) activities, including executing the current innovation pipeline and developing the future product portfolio.
As CTO, Kaltenbach will also oversee the company’s recently launched “Innovation and Growth Fund” to advance BD’s strategy and increase investments in priority R&D programs that accelerate growth.
Succeeding Kaltenbach as executive vice president and president of the Life Sciences segment is Dave Hickey, who currently serves as worldwide president of the Integrated Diagnostics Solutions business. As president of the Life Sciences segment, Hickey will oversee the Biosciences, Preanalytical Systems and Diagnostics Systems businesses worldwide.
Hickey joined BD in 2014 as vice president and general manager for the Clinical Microbiology business and was promoted to president of the Diagnostics Systems business in 2016. Prior to BD, Hickey spent 22 years with Siemens Healthcare Diagnostics in multiple positions of increasing responsibility. Hickey began his career as a clinical biochemist in the United Kingdom.
To learn more visit the BD website.